2022 European Hematology Association (EHA) Meeting

PTG-300 (Rusfertide) Treatment Interruption Reverses Hematological Gains And Restores Therapeutic Benefit On Reinitiation In Subjects With Polycythemia Vera

Kuykendall A, et al

DOWNLOAD PUBLICATION